ReCode Therapeutics Appoints Trisha Millican to Board of Directors

MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics, a genetic medicines company using superior... Read more »

Catalio Capital Management Co-Leads $27 Million Financing for Medical Informatics

Catalio Capital Management and Intel Capital have co-led a $17 million Series B equity round for Medical Informatics... Read more »

Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology... Read more »

Gain exposure through our multi-channel news platform.

A&W’s Board Certified ‘Curdiologist’ Has the Cure for What Ails You: Sriracha Cheese Curds

CCA Health California Appoints Dr. Laura Mead Clapper as Medical Director

AstraZeneca to Acquire Neogene Therapeutics for $320M

Instinct Announces Growth Equity Investment from Mainsail Partners

Biocare Medical Buys Empire Genomics

Merck to Acquire Imago BioSciences

Versant Ventures Join $107 Million Series C For Jnana Therapeutics

General Catalyst Leads $90M Series E For Maven Clinic

Contraline, Developer of Long-Term Male Contraceptive, Raises $7.2 Million in Series A Round

Indivior To Acquire Opiant Pharmaceuticals

Wheel Acquires GoodRx Care

Providence And Premier Join CommonSpirit To Support The Development Of The Healthcare Workforce

Interview with Stephen Willard, CEO of NRx Pharmaceuticals

Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 Million

Longitude Capital/Vivo Capital Join $118M Series B For Zenas BioPharma

Avalon GloboCare to Acquire a 60% Interest in Laboratory Services MSO